What Challenges Do Biotechnology Firms Face in Cancer Research?
Despite their contributions, biotechnology firms encounter several challenges in cancer research. High costs and time-consuming processes of clinical trials are significant barriers. Additionally, the complexity of cancer biology and genetic heterogeneity among patients make it difficult to develop universally effective treatments. Regulatory hurdles and the need for substantial investment in research and development further complicate the landscape. However, ongoing advancements and collaborative efforts continue to drive progress.
